>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS

October 13 - 17 2012, 12:00 AM - 12:00 AM

ANESTHESIOLOGY 2012

>

FDA MEDWATCH ALERTS

RSS

May 16, 2012

Hydromorphone Hydrochloride Recall

Summary:

Hydromorphone Hydrochloride Recall

April 18, 2012

Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume

Summary:

Customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Opioid pain medications such as morphine have life-threatening consequences if overdosed. Those consequences can include respiratory depression (slowed breathing or suspension of breathing), and low blood pressure.

March 05, 2012

Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall - Defective Component

Summary: FDA notified healthcare professionals and medical care organizations of the Class 1 recall of the listed AEDs which contain a component that may fail unexpectedly due to a defect. If the component were to fail during a rescue attempt, the AED may not deliver defibrillation therapy, causing serious adverse health consequences, including death. The unit’s self test may not detect the failure or impending failure of the component.

>

ASA FEATURED PRODUCT

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-12CE

... Read more »

Single Copies, Member Price: $300

ASA Regulatory Comment Letters

 

12-12-11 - ASA Urges CMS Revise Proposed Rules Changes on Conditions of Participation and More

12-07-11 - ASA Comment Letter on Draft Blueprint for Prescriber Education Under Opioid REMS

09-27-11 - ASA Letter to MEDPAC Regarding Proposed SGR Changes

08-31-11 ASA Comment Letter on 2012 CMS Physician Schedule Proposed Rule 

08-11-11 - ASA Joins Surgical Quality Alliance Comment Letter on Medicare Claims Data Rule

07-27-11 -  ASA Submits Comments to CMS in Regard to the Agency's NPRM on the Five Year Review

07-12-11 -  ASA Details How DEA Can Help Alleviate Drug Shortages in Comment Letter to DOJ

07-06-11 - ASA Expresses Concern to CMS over Rejection of RUC Recommendations

06-03-11 - ASA Responds to Accountable Care Organization Proposed Rule  

05-31-11 -  ASA Responds to FTC's Proposed Statement on ACO Antitrust Enforcement

02-24-11 - ASA Submits Comments to OIG on Company Model

02-18-11 - ASA Submits Comments to CMS Regarding Electronic Health Record Meaningful Use Requirements

01-03-11 - ASA Submits Comments to CMS FY2011 Physician Fee Schedule Final Rule

08-24-10 - ASA Submits Comments to CMS FY2011 Physician Fee Schedule Proposed Rule

03-15-10 -  ASA HIT Meaningful Use Comments to CMS

01-18-10 - ASA Submits Letter to CMS on Hospital Interpretive Guidelines

01-04-10 - ASA Submits Comment Letter to CMS on CY 2010 PFS Final Rule

08-26-09 - ASA submits comment letter to CMS for 2010 Physician Fee Schedule

08-21-09 - ASA submits comment letter to DEA regarding placement of Fospropofol into Schedule IV

07-10-09 - ASA Submits Comments to FDA on Opioid REMS

05-28-09 - ASA Comments to the FDA regarding SEDASYS

04-21-09 - ASA signs joint letter from Surgical Quality Alliance (SQA) regarding 2010 PQRI

03-12-09- ASA signs joint letter to CMS regarding Recovery Audit Contractor (RAC) program

02-27-09 - ASA signs joint letter to FTC regarding “Red Flags Rule”

01-05-09 -ASA joint letter to MedPAC regarding 2010 physician update

12-23-08 - ASA comments to CMS regarding “Never Events”

10-15-08 - ASA comments to CMS regarding transition to Version 5010 and ICD-10